Apheresis Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global apheresis market encompasses technologies and products used to separate and collect specific blood components from whole blood, serving both therapeutic and blood collection purposes. The market was valued at approximately $3.76 billion in 2025, with projections reaching roughly $4.41 billion by 2031, reflecting a steady growth trajectory driven by clinical demand and technological advancements in separation methodologies.

• •Market valued at approximately $3.76 billion in 2025, projected to reach around $4.41 billion by 2031
• •Products include apheresis devices and disposable consumables/kits used in both blood collection and therapeutic applications
• •Covers applications such as plateletpheresis, plasmapheresis, red blood cell collection, leukapheresis, and photopheresis

The increasing global burden of chronic diseases is a significant catalyst, as apheresis is widely employed in the management of conditions such as autoimmune disorders, neurological diseases, and renal failure requiring plasma exchange. Rising demand for blood components in transfusion medicine, coupled with growing organ and stem cell transplantation procedures, continues to expand market utilization. Additionally, increasing adoption of therapeutic apheresis for rare and complex conditions supports long-term demand across both developed and emerging markets.

• •Rising prevalence of chronic and autoimmune diseases driving therapeutic apheresis demand
• •Growing blood collection and component separation needs in transfusion medicine
• •Expanding organ and stem cell transplantation volumes increasing apheresis utilization

The market is segmented by product type, including devices and disposables and consumables, with disposables representing a recurring revenue stream tied to each apheresis procedure. Applications span plateletpheresis, plasmapheresis, RBC apheresis, and leukapheresis, while procedure types include centrifugation and membrane filtration. Geographically, North America and Europe have historically dominated due to advanced healthcare infrastructure and high procedure volumes, though Asia-Pacific is emerging as a growth region driven by expanding healthcare access and rising chronic disease incidence.

• •Product segments include apheresis devices and disposables/consumables, with disposables representing recurring procedural revenue
• •Key applications include plateletpheresis, plasmapheresis, RBC apheresis, leukapheresis, and therapeutic plasma exchange
• •North America and Europe lead in market share, while Asia-Pacific is a key growth region driven by expanding healthcare infrastructure

What are the recent trends and outlook?

Ongoing technological advancements in apheresis systems, including automation, portable platforms, and integrated monitoring capabilities, are improving procedural efficiency and patient outcomes. The growing intersection of apheresis with regenerative medicine, stem cell therapies, and cellular immunotherapy is expected to create new application opportunities over the forecast period. Continued expansion of blood donation programs and increasing awareness of component-specific transfusion therapies are likely to sustain steady market growth through 2031 and beyond.

• •Automation and integrated monitoring technologies are enhancing procedural safety and operational efficiency
• •Expanding use of apheresis in stem cell collection and regenerative medicine applications is creating new growth avenues
• •Blood collection centers and transfusion medicine programs continue to drive demand for apheresis systems globally